Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”

被引：0
|
作者：
Nicolas Simon
Jean Claude Alvarez
机构：
[1] Aix-Marseille University,APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Service de Pharmacologie Clinique, CAP
[2] Hôpitaux Universitaires Paris-Ile de France-Ouest,TV
[3] APHP,Département de Pharmacologie
[4] Hôpital Raymond Poincaré,Toxicologie
[5] FHU Sepsis,undefined
[6] MasSpecLab,undefined
[7] Plateforme de spectrométrie de masse,undefined
[8] Inserm U-1173,undefined
[9] Université Paris Saclay (Versailles Saint Quentin-en-Yvelines),undefined
来源：
European Journal of Clinical Pharmacology | 2021年 / 77卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：793 / 794
页数：1
相关论文
共 50 条
  • [31] Consultation psychiatry in COVID-19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs
    Marcatili, Matteo
    Stefana, Alberto
    Colmegna, Fabrizia
    di Giacomo, Ester
    D'Amico, Emiliano
    Capuzzi, Enrico
    Dakanalis, Antonios
    Clerici, Massimo
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (04) : 145 - 146
  • [32] Acute Kidney Injury Associated With Lopinavir/Ritonavir Combined Therapy in Patients With COVID-19
    Binois, Yannick
    Hachad, Hafsah
    Salem, Joe-Elie
    Charpentier, Julien
    Lebrun-Vignes, Benedicte
    Pene, Frederic
    Cariou, Alain
    Chiche, Jean-Daniel
    Mira, Jean-Paul
    Nguyen, Lee S.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (10): : 1787 - 1790
  • [33] Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19
    Echarte-Morales, Julio
    Minguito-Carazo, Carlos
    del Castillo-Garcia, Samuel
    Borrego-Rodriguez, Javier
    Rodriguez-Santamarta, Miguel
    Sanchez-Munoz, Enrique
    Bergel-Garcia, Ruben
    Gonzalez-Maniega, Clea
    Prieto-Gonzalez, Silvia
    Menendez-Suarez, Paula
    Tundidor-Sanz, Elena
    Benito-Gonzalez, Tomas
    Fernandez-Vazquez, Felipe
    JOURNAL OF ELECTROCARDIOLOGY, 2021, 64 : 30 - 35
  • [34] Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients
    Schneider, Johanna
    Jaenigen, Bernd
    Wagner, Dirk
    Rieg, Siegbert
    Hornuss, Daniel
    Biever, Paul M.
    Kern, Winfried V.
    Walz, Gerd
    PLOS ONE, 2021, 16 (05):
  • [35] Lopinavir-ritonavir versus darunavir-norvir for hospitalized COVID-19 patients
    Paroczai, Dora
    Bikov, Andras
    Blidaru, Andreea
    Bobu, Emanuel
    Cerbu, Bianca
    Marincu, Iosif
    Mihaicuta, Stefan
    Frent, Stefan
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [36] Efficacy and Safety of Atazanavir/Ritonavir Versus Lopinavir/Ritonavir in Hospitalized COVID-19 Patients: A Randomized Clinical Trial
    Siami, Zeinab
    Dehghan, Danial
    Khavandegar, Armin
    Lak, Mehran
    Bakhtiyari, Mahmood
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2022, 24 (05)
  • [37] Letter to the editor: COVID-19 IN UNDERLYING COPD PATIENTS
    Sunkara, Krishna
    Allam, Venkata Raj
    Shukla, Shakti D.
    Chellappan, Dinesh K.
    Gupta, Gaurav
    MacLoughlin, Ronan
    Dua, Kamal
    EXCLI JOURNAL, 2021, 20 : 248 - 251
  • [38] Reply to the Letter to the Editor, "Tracheostomy in the COVID-19 Era: The Apneic Approach"
    Riestra-Ayora, Juan
    Yanes-Diaz, Joaquin
    Martin-Sanz, Eduardo
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 163 (06) : 1284 - 1284
  • [39] Letter to the Editor: Statins and COVID-19: Efficacy Still to Be Proven Reply
    Bloom, Patricia P.
    Chung, Raymond T.
    HEPATOLOGY, 2021, 73 (02) : 875 - 876
  • [40] Assessing the Clinical Improvement in Patients with COVID-19 using Lopinavir-Ritonavir: A Systematic Review
    Magadmi, Rania M.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (44A) : 448 - 459
12345